ReviewOncotarget2016
Does an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma?
Mérédis Favreau et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ReviewOncotarget2016
Mérédis Favreau et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.